Market Overview

Medullary Thyroid Cancer: 2018 Pipeline Insights featuring Novartis, Bayer, AbbVie, Boehringer, Celgene and others - ResearchAndMarkets.com

Share:

The "Medullary
Thyroid Cancer - Pipeline Insight, 2018"
drug pipelines has
been added to ResearchAndMarkets.com's offering.

This report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Medullary
Thyroid Cancer development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental
Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

The report assesses the active Medullary Thyroid Cancer pipeline
products by developmental stage, product type, molecule type, and
administration route.

Scope

  • The report provides a snapshot of the pipeline development for the
    Medullary Thyroid Cancer
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    the Medullary Thyroid Cancer
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Medullary Thyroid Cancer
  • The report also covers the dormant and discontinued pipeline projects
    related to the Medullary Thyroid Cancer

Companies Mentioned

  • AbbVie Inc.
  • Advenchen Laboratories
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Hutchison MediPharma Limited
  • Immunomedics
  • Nerviano Medical Sciences S.r.l.
  • Novartis AG

Key Topics Covered

1. Report Introduction

2. Medullary Thyroid Cancer Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Products in Clinical Stage

6. Products in Pre-Clinical and Discovery Stage

7. Therapeutic Assessment

8. Inactive Products

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/563dzd/medullary_thyroid?w=4

View Comments and Join the Discussion!